Understanding Acyanotic Congenital Heart Defects: A Comprehensive Exploration

Congenital heart defects (CHDs) are structural abnormalities present at birth, affecting the normal functioning of the heart. Acyanotic congenital heart defects represent a subset of these conditions, characterized by the absence of bluish discoloration (cyanosis) in the skin, indicating sufficient oxygen levels in the blood. This article delves into the intricate world of acyanotic CHDs, exploring their types, causes, diagnosis, and potential treatment options.

I. Definition and Types of Acyanotic Congenital Heart Defects:

Acyanotic congenital heart defects are characterized by abnormal blood flow patterns that, unlike cyanotic defects, do not lead to low oxygen levels in the bloodstream. The two primary types of acyanotic CHDs are:

A. Left-to-Right Shunts:

1. Atrial Septal Defect (ASD): A hole in the septum (wall) between the two upper chambers (atria) of the heart, allowing oxygenated blood from the left atrium to mix with deoxygenated blood in the right atrium.
2. Ventricular Septal Defect (VSD): Similar to ASD, but the hole is located in the septum between the two lower chambers (ventricles), allowing blood to flow from the left ventricle to the right.

B. Obstructive Lesions:

1. Coarctation of the Aorta: Narrowing of the aorta, the main artery carrying oxygenated blood from the heart, restricting blood flow to the lower part of the body.
2. Aortic Stenosis: Narrowing of the aortic valve, hindering the flow of blood from the left ventricle into the aorta.

II. Causes of Acyanotic Congenital Heart Defects:

While the exact causes of acyanotic CHDs often remain unclear, a combination of genetic and environmental factors plays a role in their development. Factors that may contribute include:

A. Genetic Factors:Inherited 

1. Mutations: Genetic abnormalities passed down from parents may increase the risk of certain acyanotic CHDs.
2. Chromosomal Disorders: Conditions such as Down syndrome may be associated with a higher prevalence of congenital heart defects.

B. Environmental Factors:

1. Maternal Illnesses: Infections or illnesses during pregnancy, such as rubella, can increase the risk of acyanotic CHDs.
2. Medications: Certain medications taken during pregnancy may contribute to the development of congenital heart defects.

III. Diagnosis of Acyanotic Congenital Heart Defects:

A. Prenatal Diagnosis:

1. Ultrasound: High-resolution ultrasound during pregnancy can detect structural abnormalities in the developing fetus, allowing for early diagnosis.
2. Fetal Echocardiography: Specialized ultrasound focusing on the fetal heart provides detailed images and helps identify acyanotic CHDs.

B. Postnatal Diagnosis:

1. Clinical Examination: Physical examination of the newborn, including assessment of heart sounds, breathing patterns, and overall health.
2. Echocardiography: A non-invasive imaging test using sound waves to create detailed images of the heart's structure and function.

IV. Symptoms and Complications:

A. Common Symptoms:

1. Fatigue and Weakness: Due to inefficient pumping of blood.
2. Shortness of Breath: Especially during physical activity.
3. Failure to Thrive: Insufficient weight gain and growth in infants.

B. Complications:Pulmonary 

1. Hypertension: Increased blood pressure in the arteries of the lungs, potentially leading to heart failure.
2. Arrhythmias: Irregular heart rhythms may develop, affecting the heart's ability to pump blood effectively.

V. Treatment Options:

A. Medications:

1. Diuretics: To reduce fluid buildup and alleviate symptoms.
2. Inotropes: To strengthen the heart's contractions.

B. Surgical Interventions:

1. Closure of Septal Defects: Surgical closure or catheter-based procedures for ASDs and VSDs.
2. Repair or Replacement of Valves: Surgical correction of obstructive lesions such as aortic stenosis.

C. Catheter-based Interventions:

1. Balloon Angioplasty: To widen narrowed blood vessels.
2. Stent Placement: For maintaining the patency of vessels like the aorta.

VI. Prognosis and Long-term Management:

A. Prognosis:

1. Varies by Condition: The outlook depends on the specific type and severity of the acyanotic CHD.
2. Early Intervention Improves Prognosis: Timely diagnosis and appropriate treatment contribute to better outcomes.

B. Lifelong Follow-up:

1. Regular Monitoring: Individuals with acyanotic CHDs require ongoing medical supervision.
2. Adaptations for Daily Living: Lifestyle adjustments and activity limitations may be recommended based on the individual's condition.

VII. Research and Advances:

A. Genetic Research:

1. Identification of Risk Factors: Ongoing research aims to identify specific genetic factors contributing to acyanotic CHDs.
2. Precision Medicine: Advancements in understanding genetic components may lead to more personalized treatment approaches.

B. Innovations in Interventional Cardiology:

1. Device Therapies: Development of advanced devices for minimally invasive procedures.
2. Catheter-based Techniques: Continued refinement of techniques for catheter-based interventions.

C. Fetal Interventions:

In Utero Treatments: Explorations into interventions during fetal development to correct or mitigate acyanotic CHDs.

VIII. Conclusion: Embracing Progress and Hope

In the realm of acyanotic congenital heart defects, medical advancements and ongoing research offer hope for improved diagnosis, treatment, and long-term management. As our understanding of the genetic and environmental factors contributing to these conditions deepens, so does the potential for more effective interventions and personalized care.

The journey of individuals living with acyanotic CHDs involves not only the challenges posed by their condition but also the resilience and determination to lead fulfilling lives. By fostering awareness, supporting ongoing research, and embracing a multidisciplinary approach to care, we contribute to a future where individuals with acyanotic congenital heart defects can thrive and continue to inspire others with their stories of strength and perseverance.

Navigating the Complex Landscape of Congenital Heart Defects: Understanding, Challenges, and Hope

Congenital heart defects (CHDs) stand as a multifaceted challenge within the realm of medical conditions, affecting individuals from birth and demanding a nuanced understanding of both their complexity and the hope for effective interventions. In this comprehensive exploration, we delve into the intricate world of congenital heart defects, examining their nature, causes, impact, and the strides made in diagnosis and treatment. As we unravel the layers of this condition, we also shed light on the resilience of those affected and the ongoing efforts to enhance the lives of individuals living with congenital heart defects.

I. Understanding Congenital Heart Defects:

A. Definition and Scope:

Congenital heart defects refer to structural abnormalities in the heart that are present at birth. These defects can affect the heart's walls, valves, arteries, or veins, disrupting the normal flow of blood. CHDs vary widely in severity, from simple defects that may never cause symptoms to complex conditions that require immediate medical intervention.

B. Types of Congenital Heart Defects:

Septal Defects: These involve holes in the heart's walls, leading to abnormal blood flow between its chambers. A common example is atrial septal defect (ASD) or ventricular septal defect (VSD).

Valvular Defects: Conditions like stenosis (narrowing) or regurgitation (leaking) of heart valves can impede blood flow and strain the heart's function.

Cyanotic Defects: These defects cause a shortage of oxygen in the blood, leading to a bluish tint in the skin and lips. Tetralogy of Fallot is a notable example.

Obstructive Defects: Conditions such as coarctation of the aorta or pulmonary stenosis create obstacles to blood flow, requiring the heart to work harder.

C. Causes of Congenital Heart Defects:

While the exact causes of CHDs often remain unknown, a combination of genetic and environmental factors contributes to their development. Genetic mutations, maternal illnesses or medications during pregnancy, and exposure to certain environmental factors may increase the risk of CHDs.

II. Diagnosis and Screening:

A. Prenatal Screening:

Advancements in medical technology have enabled the detection of congenital heart defects during pregnancy. Fetal echocardiography, a specialized ultrasound, allows healthcare professionals to assess the structure and function of the fetal heart, aiding in early diagnosis and intervention.

B. Postnatal Diagnosis:

Some congenital heart defects are diagnosed soon after birth through physical exams and observations of the newborn's color, breathing patterns, and overall health. Further diagnostic tools, such as echocardiography, electrocardiography (ECG or EKG), and imaging studies like magnetic resonance imaging (MRI), help healthcare providers assess the severity and type of CHD.

III. Challenges and Impact:

A. Medical Complexity:

The medical complexity of congenital heart defects can vary widely, with some cases requiring immediate intervention, while others may not surface until later in life. The intricate nature of these conditions demands a multidisciplinary approach, involving pediatric cardiologists, cardiothoracic surgeons, and other specialists.

B. Emotional and Psychological Impact:

The diagnosis of a congenital heart defect often brings emotional and psychological challenges for both individuals and their families. Coping with the uncertainty, potential surgeries, and long-term medical care can be overwhelming. Support networks, counseling services, and patient advocacy groups play crucial roles in helping families navigate these challenges.

C. Lifelong Management:

While advancements in medical science have significantly improved outcomes for individuals with congenital heart defects, many require lifelong management. This may involve medication, routine check-ups, and, in some cases, multiple surgeries throughout their lives.

IV. Treatment and Interventions:

A. Medications:

Certain medications can help manage symptoms and improve the heart's function. Diuretics, anticoagulants, and medications to regulate blood pressure may be prescribed based on the specific needs of the individual.

B. Surgical Interventions:

Many congenital heart defects require surgical interventions to correct structural abnormalities. Procedures range from closing septal defects to repairing or replacing heart valves. The timing of surgery depends on factors such as the severity of the defect and the overall health of the individual.

C. Interventional Cardiology:

Advancements in interventional cardiology have led to less invasive procedures for certain congenital heart defects. Catheter-based interventions, such as balloon angioplasty or stent placement, can be used to address issues like narrowed blood vessels or valve problems without the need for open-heart surgery.

V. Research and Advances:

A. Genetic Research:

Ongoing genetic research holds promise for identifying the underlying genetic factors contributing to congenital heart defects. Understanding the genetic basis of CHDs may lead to targeted therapies and more personalized treatment approaches.

B. Fetal Interventions:

Research in fetal medicine is exploring the possibility of interventions while the baby is still in the womb. This groundbreaking field aims to correct or alleviate certain congenital heart defects before birth, potentially improving long-term outcomes.

C. Stem Cell Therapy:

Explorations into stem cell therapy for congenital heart defects offer potential avenues for regenerating damaged cardiac tissue. While in the early stages of research, this innovative approach holds promise for future treatment modalities.

VI. Living with Congenital Heart Defects:

A. Patient Advocacy and Support:

Patient advocacy groups and support networks play a vital role in empowering individuals living with congenital heart defects and their families. These communities provide resources, emotional support, and platforms for sharing experiences, fostering a sense of connection and understanding.

B. Lifestyle Considerations:

Individuals with congenital heart defects often benefit from adopting heart-healthy lifestyles. Regular exercise, a balanced diet, and appropriate medical management contribute to overall well-being. However, it's crucial to consult healthcare professionals to determine the most suitable lifestyle choices for each individual case.

C. Advancements in Adult Congenital Heart Care:

With improved medical interventions and long-term management strategies, more individuals with congenital heart defects are surviving into adulthood. Specialized care for adults with congenital heart disease is emerging as a critical field, addressing the unique challenges faced by this growing population.

VII. Conclusion: Embracing Hope and Resilience

In the intricate tapestry of congenital heart defects, each thread tells a story of resilience, medical advancements, and the enduring human spirit. The journey of those affected by CHDs encompasses challenges, triumphs, and the unwavering pursuit of a fulfilling life. As research progresses, treatment options expand, and support networks strengthen, there is hope that the narrative surrounding congenital heart defects will continue to evolve, emphasizing not only the complexities but also the possibilities for a brighter and healthier future. By fostering awareness, advancing medical knowledge, and embracing a holistic approach to care, we can collectively contribute to a world where individuals with congenital heart defects can thrive and lead fulfilling lives.

PDA (Patent Ductus Arteriosus) - A Parents' Guide For Premature Babies

As a parent in the NICU I lost count of how many times I got the PDA demonstration. I think most nurses love to demonstrate their medical knowledge and the PDA is something that they all feel they know something about. Out comes the giant picture of the blue and red heart and then comes the spiel. I heard it enough times that I should know it verbatim. Unfortunately every version was different, so without further research I would have been left confused. I often noticed other couples getting the cot-side impromptu presentation nodding along furiously then looking bemusedly at each other when the nurse disappeared.

PDA stands for Patent Ductus Arteriosus. Patent in this sense means "open", not "shiny" as in patent leather shoes. So, the Ductus Arteriosus is open, it should be closed.

What is the Ductus Arteriosus?

Pre-birth we all live in water, amniotic fluid. There's an argument that even after birth we all live in water, only we carry our ocean around with us. The word "amniotic" comes from the Ancient Greek word for bowl. So, as we live our pre-birth goldfish like existence in our bowl of water, how do we breathe? Well, our mothers do our breathing for us. Oxygenated blood is passed through the placenta from the mother to the fetus, thus leaving the fetus' lungs alone to concentrate on developing. That is why they are the last of the organs to develop before birth. This is also why so many premature babies have breathing difficulties and are constantly monitored for oxygen saturation. It is very difficult for the premature baby to maintain suitable oxygen saturation in her own blood using her own undeveloped lungs. To compensate for this, the baby is given an air supply with more concentrated oxygen levels than normal air (which is around 21% oxygen, the rest being mostly nitrogen).

So, what does the DA do? Well, when it is "patent" (ie "open") it allows the blood to flow through the heart without going through the lungs. There's no point pushing the blood through the lungs when they are immature and fluid-filled, they can not yet oxygenate the blood. In a full-term birth, the duct will close itself off anywhere from a few hours after birth to a few weeks. It does this by becoming more fibrous and eventually sealing itself off.

What does this mean for a Premmie?

In most preterm births the PDA will remain. The amount it is open is normally described in millimeters and can be anything from less than half a millimeter open to a few millimeters open. Normally, a PDA is evident to the doctor listening through a stethoscope as a background murmuring like a motorbike. An echo-cardiogram will almost certainly be performed to measure how open the duct is. This is a simple non-invasive test, just like an ultrasound.

After the test, the doctors will determine a course of action to close the DA if required. Well, that's if you're in a NICU which has a philosophy of closing PDAs. Like many matters in the NICU, there will be a philosophy in that Unit which is unique to that unit. Some will try to close the PDA with gusto, others will decide if the PDA is "hematologically significant" and take action based on that. That means, they will decide if the DA being open is a problem or not.

Treatment will either be pharmaceutical or surgical. The surgery is relatively uncomplicated. They will "ligate" the PDA, ie tie it off. Normally they will opt for a pharmaceutical approach to begin with. Commonly, a course of indomethacin is prescribed. The indomethacin is normally given as a course, the frequency and strength of which again will vary from NICU to NICU. Why this would vary is not clear to me. Surely some consensus of medical best practice has been reached and adopted by all clinicians? Not so, unfortunately. This variability is a recurring theme for most most decisions concerning premature babies. All I can suggest is that you research thoroughly, arm yourself with as much knowledge as you can and not be afraid to ask questions in the NICU. There really is no such thing as a stupid question.

In some countries a more successful drug for closing the PDA has been Ibuprofen, which is commonly taken for headaches. This isn't approved for use in all countries yet though, so may or may not be offered depending on your location.

Hopefully, the first course of drugs will close the PDA or at least reduce it to a size that is no longer significant. If not, another course of indomethacin may be prescribed. From memory, it has around a 30% efficacy so two courses will make it more likely than not that the DA will be closed but it is still reasonably possible that it won't be. There's a limit to how many courses of indomethacin will be administered. Two in our case, but again this will depend on the dosage used, which is variable unit to unit. Hopefully by this point the DA will now be significantly smaller. If not, surgery will probably be necessary. This surgery is a lot less invasive than it used to be.

( Scott L Miller ) 

General Information About Congenital Anomalies

Congenital anomaly is a mental or physical abnormality that is present at, and usually before, birth. Some anomalies may be medically insignificant and may not appear for some time. In other cases, the anomaly may pose a direct threat to life and requires immediate attention. There are, however, some anomalies that cannot be treated.

Question: What are examples of congenital anomalies?

Congenital anomalies include bone disorders, cataract, cleft palate, cretinism, Down's syndrome, congenital heart disease, hemophilia, joint disorders, pyloric stenosis, and spina bifida. Blindness, deafness, hydrocephalus, and jaundice are also often due to congenital anomalies, although in other cases they are the result of event that occurred after birth.

Limbs or organs may be malformed, duplicated, or entirely absent. Organs may fail to move to the correct place, as in cryptorchidism; fail to open correctly as in imperforate anus; or fail to close at the correct time, as in patent ductus arteriosus. Congenital anomalies often occur together. For example, 33 percent of babies born with Down's syndrome also have heart disease.

Question: What may cause the development of congenital anomalies?

They arise from the faulty development of a fetus, caused either by genetic disorders or other factors. Some anomalies arise from a combination of factors, and the underlying cause is far from clear in all cases.

Question: How are genetic disorders responsible for congenital anomalies?

Inherited congenital anomalies generally result from the presence of abnormal genes or chromosomes. Heredity is determined by corresponding pairs of genes, called alleles. One of these paired genes is dominant and the other recessive, and it is the dominant gene that governs the transmitted trait or characteristic. Thus, if the abnormal gene of a pair is dominant, the abnormal or anomalous trait will be conveyed to the embryo. If the abnormal gene is recessive, then both genes in the pair have to be abnormal for a congenital anomaly to occur.

Some congenital anomalies, such as hemophilia, are linked to a defect of one of the sex chromosomes. Many genetic disorders, however, are neither wholly dominant, recessive, nor sex-linked, but may be caused by more than one abnormal pair of genes.

Question: What other factors may cause congenital anomalies?

Infection in the mother is a common cause of abnormality in a baby. For example, an attack of rubella during the first three months of pregnanacy may cause her child to be born deaf or have cataracts, heart disease, jaundice, or other anomalies. Cytomegalovirus (CMV) and toxoplasmosis also cause congenital anomalies.

Certain drugs taken by a woman during pregnancy are often responsible for abnormalities in the child. For example, large doses of corticosteroids can cause a variety of congenital defects, as can some anticonvulsants given to control epilepsy. Other drugs include anticancer drugs; narcotics and sedatives; tranquilizers and antidepressants; antibacterials, especially tetracycline; anticoagulants; drugs prescribed to treat cardiac conditions and hypertension; oral hypoglycemic used to treat diabetes in the mother; and, of course, heavy consumption of alcohol. Other drugs may cause gross abnormalities, such as the defects arising from thalidomide. A pregnant woman should, thus, avoid taking any medication without first consulting with her physician.

Injury to a pregnant woman or to a fetus is another cause of congenital anomalies. For example, limbs may be malformed if an intrauterine device (IUD) is not removed early in the pregnancy. Smoking during pregnancy is implicated as one factor in the incidence of abnormally low birth weight in babies, and malnutrition seems to be related to a high incidence of congenital anomalies. The age of the woman at the time she conceives can also be a factor. For example, Down's syndrome occurs more frequently when conception occurs after the age of about 35.

Congenital anomalies have also been attributed to the effects of X-ray examination made early in a pregnancy.

Question: Is it possible to diagnose congenital anomalies in a fetus?

Yes. The most reliable method of diagnosis is to examine a sample of fluid from the amniotic sac, sometime between the fifteenth and eighteenth week of pregnancy. The sample is obtained by amniocentesis. Microscopic examination of the cells in the fluid then reveals possible abnormalities in the chromosomes. Congenital anomalies that can be diagnosed in this way include Down's syndrome, spina bifida, and anencephaly. Sometimes, the diagnostic use of ultrasound can detect abnormalities of the skull or spine.

Question: Can congenital anomalies be treated?

Treatment depends entirely on the nature and severity of the condition. Many anomalies can be treated, but for some there is no treatment.

Question: In what circumstances might abortion be considered?

Abortion might be considered if serious fetal disorders are found early in a pregnancy. The decision to abort rests with the parents and is made after considering the advice of the physician and specialists on the nature of the disorder and the consequences of abortion.

Question: Are congenital anomalies more likely to occur in first-born babies?

No. Statistics disprove this commonly held belief.

Question: Does a congenital anomaly in a baby indicate that subsequent babies will be similarly affected?

Genetic counseling deals with such questions. In many cases it is possible to state risks numerically. For example, a baby with congenital heart disease is likely to be followed by a similarly affected child in 2 percent of pregnancies instead of the ordinary risk of one percent. Spina bifida occurs in about 1 child in every 1,500, but if a previous child was born with the condition, there is about a 1-in-20 to 1-in-50 chance that it will occur in a later child.

( Amaury Hdz Aguila ) 

Heart Diseases Part IX - Congenital Heart Disease

Congenital heart diseases affect any part of the heart such as heart muscle, valves, and blood vessels. Congenital heart disease refers to a problem with the heart's structure and function due to abnormal heart development before birth. Every year over 30,000 babies are born with some type of congenital heart defect in US alone.

Congenital heart disease is responsible for more deaths in the first year of life than any other birth defects. Some congenital heart diseases can be treated with medication alone, while others require one or more surgeries. The causes of congenital heart diseases of newborns at birth may be in result from poorly controlled blood sugar levels in women having diabetes during pregnancy, some hereditary factors that play a role in congenital heart disease, excessive intake of alcohol and side affects of some drugs during pregnancy. Congenital heart disease is often divided into two types: cyanotic which is caused by a lack of oxygen and non-cyanotic.

1. Cyanotic 

Cyanosis is a blue coloration of the skin due to a lack of oxygen generated in blood vessels near the skin surface. It occurs when the oxygen level in the arterial blood falls below 85-90%. The below lists are the most common of cyanotic congenital heart diseases:

a)Tetralogy of fallot - Tetralogy of fallot is a condition of several congenital defects that occur when the heart does not develop normally. It is the most common cynaotic heart defect and a common cause of blue baby syndrome.

b)Transportation of the great vessels - Transportation of the great vessels is the most common cyanotic congenital heart disease. Transposition of the great vessels is a congenital heart defect in which the 2 major vessels that carry blood away from the aorta and the pulmonary artery of the heart are switched. Symptoms of transportation of the great vessels include blueness of the skin, shortness of breath and poor feeding.

c)Tricuspid atresia - In tricuspid atresia there is no tricuspid valve so no blood can flow from the right atrium to the right ventricle. Symptoms of tricuspid atresia include blue tinge to the skin and lips, shortness of breath, slow growth and poor feeding.

d)Total anomalous pulmonary venous return - Total anomalous pulmonary venous return (TAPVR) is a rare congenital heart defect that causes cyanosis or blueness. Symptoms of total anomalous pulmonary venous return include poor feeding, poor growth, respiratory infections and blue skin.

e)Truncus arteriosus - Truncus arteriosus is characterized by a large ventricular septal defect over which a large, single great vessel arises. Symptoms of truncus arteriosus include blue coloring of the skin, poor feeding, poor growth and shortness of breath. There are many more types of cyanotic such as ebstein's anomaly, hypoplastic right heart, and hypoplastic left heart. If you need more information please consult with your doctor.

2. Non-cyanotic 

Non-cyanotic heart defects are more common because of higher survival rates. The below lists are the most common of non-cyanotic congenital heart diseases:

a)Ventricular septal defect - Ventricular septal defect is a hole in the wall between the right and left ventricles of the heart causing right and left ventricles to work harder, pumping a greater volume of blood than they normally would in result of failure of the left ventricle. Symptoms of ventricular septal defect include very fast heartbeats, sweating, poor feeding, poor weight gain and pallor.

b)Atrial septal defect - Atrial septal defect is a hole in the wall between the two upper chambers of your heart causing freshly oxygenated blood to flow from the left upper chamber of the heart into the right upper chamber of the heart. Symptoms of atrial septal defect include shortness of breath, fatigue and heart palpitations or skipped beats.

c)Coarctation of aorta - Coarctation of aorta is a narrowing of the aorta between the upper-body artery branches and the branches to the lower body causing your heart to pump harder to force blood through the narrow part of your aorta. Symptoms of coarctation of aorta include pale skin, shortness of breath and heavy sweating.

There are many more types of non-cyanotic such as pulmonic stenosis, patent ductus arteriorus, and atrioventricular cana. These problems may occur alone or together. Most congenital heart diseases occur as an isolated defect and is not associated with other diseases.

( Kyle J Norton )

Pediatric Cardiac Surgery - Understanding Congenital Heart Defects

Congenital heart defects are a malformation in one or more structures of the heart or blood vessels that occurs before a child is born, during the development of the fetus. This developmental defect can affect approximately 8 out of every 1000 children and stems from a variety of causes. While some expectant mothers will fault their own actions when this occurs, fearing the worst for their children, modern technology has brought us to a point where traditional treatments using medication and pediatric cardiac surgery are able to correct most heart defects.

Pediatric Heart Surgery - The Underlying Cause of Congenital Heart Defects

In the majority of patients, the cause for their congenital heart defect is not directly or readily known. Through research however, pediatric specialists have discovered a number of factors that can contribute to or are associated with an increased chance of a child developing a congenital heart defect. This includes:

* Genetic abnormalities or abnormalities in the chromosomes (e.g. - Down syndrome)

* Alcohol or recreational drug use/abuse during pregnancy

* Taking certain prescription medications during pregnancy

* Viral infections during the first trimester of pregnancy, such as rubella

In cases where there is a family history of heart defects, a child has double the chance (16 in 1000) of being born with a defect that may require corrective pediatric cardiac surgery or some other form of treatment.

Defining Congenital Heart Defects

There are several defects that are detected and treated early on in infancy.

Heart Valve Defects - Any one or more of the valves in the heart may malfunction through narrowing or stenosis. Also, complete closure of a valve that impeded/prevents blood flow can occur. Other heart defects include leaky valves that don't close. This reduces the pressure, forces the heart to work harder and allows blood to leak backwards as the chambers of the heart compress.

Patent Ductus Arteriosus - This defect allows blood to bypass the lungs as it circulates, forcing unoxygenated blood back through the body. This starves the body of oxygen and as a result the heart must work harder to oxygenate the tissues of the body.

Transposition of Greater Vessels - Blood from the left and the right side of the heart intermix because the arterial connections in the heart are incorrect.

Aortic Coarctation - This is a pinched Aorta. The narrowing of the Aorta can increase pressure and reduce circulation through the body, creating a variety of symptoms including a failure to thrive. It may also be present with no symptoms.

Pediatric Cardiac Surgery - Diagnosing Congenital Heart Disease

It's important to note that while congenital defects typically develop early on, they can be diagnosed before birth, after birth, throughout childhood later in life when the patient is an adult. For some adults, they live with a heart defect and present with no symptoms or issues. Depending on the patient, the assumed defect, the age of child and other factors, a number of tests can be ordered to check for and confirm a diagnosis. This includes:

* Echocardiogram

* Cardiac Catheterization

* Chest X-ray

* Electrocardiogram

* MRI

Pediatric Heart Surgery & Other Treatments for Congenital Heart Defects

It's typical for congenital heart defects in children to require pediatric cardiac surgery or some kind of interventional procedure in order to repair the defect. To ensure the heart is able to recover and grow normally after birth, children are often treated with medication to help improve the function of the heart after surgical repairs are complete.

Grote Pitman Campbell

Hole In Heart - Congenital Heart Defect

If you have a hole in heart then you could be in big trouble. This is what is called a congenital heart defect and occurs between the chambers of the heart in the tissues that separate the chambers called the septum.

Congenital heart defects, or septal defects, are fairly common, according to the AHA, or American Heart Association. The AHA estimates that approximately 1.3 million people have this type of heart defect. These defects can have quite serious side effects.

The first and foremost symptom that may be noticed is an arrhythmia. An arrhythmia is when the heart is unable to beat a nice constant rhythm. The heart beat is erratic and speeds up or slows down at irregular intervals. The heart can even skip a beat or two. If the heart muscle stretches out due to blood pumping between the chambers then the heart will not ever be the same and cannot recover. You may be able to tell you have an arrhythmia just by feeling your heart beat. If it seems irregular, talk to your doctor about the causes.

Another problem that may arise with a hole in heart is pulmonary hypertension. Blood is pumped from the right lower ventricle of the heart to the lungs to get oxygen. Then the blood goes back to the heart where it is supposed to be pumped through to the rest of the body.

If there is a septal defect the blood really does not know exactly where to go and the heart has to work so much harder to get the blood from the wrong chamber to the correct one. 

When bad blood continually mixes with good blood then the arterial walls start to change and they get thicker increasing the pressure of the blood flowing through them. This can be a precursor to congestive heart failure, a very serious condition.

Because the blood is not flowing normally, then the chance for blood clots forming in the heart and traveling to other parts of the body is enormous. If the blood pools in the right side of the heart and there is a septal defect the clot can travel through the defect to the left side of the heart and get pumped out to any number of bodily structures, including the brain. This is called a stroke, also, very serious.

When the heart has a hole in it, it has to work a lot harder than a normal heart. The energy drain on the rest of the body is huge and there is not much left for the body to have for normal growth and development. This is called failure to thrive. Children with this condition just do not seem to ever have enough energy to play like the other normal kids.

Because the heart has to work harder it gets taxed. Well, these are some taxes that it may not be able to pay for an extended period of time. This is called heart failure. If too many arterial changes have occurred because a hole in heart caused pulmonary hypertension, the heart will eventually fail.

"This article is not to be considered medical advice of any kind and is only for informational and entertainment purposes only. As always you, the reader, should consult with your personal physician or another Licensed Health Professional."

Tomazu Scurcia